These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 4084339)
1. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: effects on cardiac conduction. Hidaka T; Hamasaki S; Aisaka K; Ishihara T; Morita M; Toyama J; Yamada K Arzneimittelforschung; 1985; 35(9):1381-6. PubMed ID: 4084339 [TBL] [Abstract][Full Text] [Related]
2. Effects of N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate on the ventriculo-atrial conductivity of accessory pathways. Satoh S; Watanabe J; Keitoku M; Kinoshita H; Sekiguchi N; Endoh S; Ohtsuka K; Hangai K; Morita M; Takishima T Arzneimittelforschung; 1989 Aug; 39(8):908-11. PubMed ID: 2818680 [TBL] [Abstract][Full Text] [Related]
3. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system. Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380 [TBL] [Abstract][Full Text] [Related]
4. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent. Aisaka K; Hidaka T; Inomata N; Hamasaki S; Ishihara T; Morita M Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441 [TBL] [Abstract][Full Text] [Related]
5. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 3rd communication: effect on cardiovascular system. Aisaka K; Hidaka T; Hattori Y; Inomata N; Ishihara T; Satoh F Arzneimittelforschung; 1988 Oct; 38(10):1417-25. PubMed ID: 3196382 [TBL] [Abstract][Full Text] [Related]
6. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction. Hashimoto H; Satoh N; Nakashima M J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123 [TBL] [Abstract][Full Text] [Related]
7. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 2nd communication: effect on the peripheral nervous system and peripheral organs. Hirotsu I; Kihara T; Hattori Y; Hatta M; Hirose N; Ishihara T; Satoh F Arzneimittelforschung; 1988 Oct; 38(10):1410-7. PubMed ID: 3196381 [TBL] [Abstract][Full Text] [Related]
9. Effect of lidocaine and methyl lidocaine on cardiac conduction. Man RY; Dresel PE J Pharmacol Exp Ther; 1977 Apr; 201(1):184-91. PubMed ID: 850138 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic effects of asocainol, a new antiarrhythmic agent with predominant class I action. Thale J; Gülker H; Hagemense B; Rose D; Haverkamp W; Frenking B Arzneimittelforschung; 1987 Jan; 37(1):14-6. PubMed ID: 3566851 [TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362). Bergey JL; Sulkowski T; Much DR; Wendt RL Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506 [TBL] [Abstract][Full Text] [Related]
12. Effect of encainide and its two major metabolites on cardiac conduction. Dresel PE J Pharmacol Exp Ther; 1984 Jan; 228(1):180-6. PubMed ID: 6420542 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiological effects of penticainide in the anaesthetized dog. Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440 [TBL] [Abstract][Full Text] [Related]
14. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304 [TBL] [Abstract][Full Text] [Related]
15. Comparative direct electrophysiological effects of propofol on the conduction system and ionic channels of rabbit hearts. Wu MH; Su MJ; Sun SS Br J Pharmacol; 1997 Jun; 121(4):617-24. PubMed ID: 9208126 [TBL] [Abstract][Full Text] [Related]
16. Experimental study on the electrophysiological effects of the combination of the antiarrhythmic drugs aprindine and verapamil. Okishige K; Ohtomo K; Satoh T; Hiejima K Arch Int Pharmacodyn Ther; 1991; 314():44-56. PubMed ID: 1824189 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo electrocardiographic evaluation of the novel calcium antagonist monatepil on cardiac conduction system. Nose I; Kataoka T; Honda Y; Yamada T; Ikeno A; Fukuya F; Minato H; Takeyama K; Hosoki K; Karasawa T Arzneimittelforschung; 1993 Jul; 43(7):722-8. PubMed ID: 8369002 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic, haemodynamic and antiarrhythmic effects of the new class Ic agent 1-(2'-biphenyloxy)-2-tert.-butylamino-propanol-2-hydrochloride. Chiladakis I; Hindricks G; Haverkamp W; Vogt J; Gülker H Arzneimittelforschung; 1989 Sep; 39(9):1130-2. PubMed ID: 2590263 [TBL] [Abstract][Full Text] [Related]
19. Electrophysiological effects of carocainide (770207) on the dog heart. Huerta F; Santamaria R; Pourrias B Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):289-98. PubMed ID: 6712362 [TBL] [Abstract][Full Text] [Related]
20. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]. Lynch JJ; Wallace AA; Stupienski RF; Baskin EP; Beare CM; Appleby SD; Salata JJ; Jurkiewicz NK; Sanguinetti MC; Stein RB J Pharmacol Exp Ther; 1994 May; 269(2):541-54. PubMed ID: 7802864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]